Immunitybio Inc Net Asset Quality Index
Immunitybio Inc net asset quality index. Immunitybio Inc (IBRX) has a Net Asset Quality Index of -9.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $518.99 Million minus total liabilities of $569.82 Million yields net assets of $-50.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore IBRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Immunitybio Inc (2013–2024)
Net asset quality index of Immunitybio Inc from 2013 to 2024. This chart shows how Immunitybio Inc's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at -9.8%, representing net assets of $-50.83 Million against total assets of $518.99 Million USD. See IBRX net assets for net asset value and shareholders' equity analysis.
Immunitybio Inc Net Asset Quality Index by Year (2013–2024)
Immunitybio Inc net asset quality index by year from 2013 to 2024. The table below presents the year-by-year Net Asset Quality Index for Immunitybio Inc from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see IBRX market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -127.5% | $-488.13 Million | $382.93 Million | $871.06 Million | ▼ -11.3 pp |
| 2023 | -116.2% | $-585.94 Million | $504.45 Million | $1.09 Billion | ▲ +8.0 pp |
| 2022 | -124.1% | $-449.82 Million | $362.36 Million | $812.18 Million | ▼ -72.1 pp |
| 2021 | -52.0% | $-243.91 Million | $468.91 Million | $712.82 Million | ▲ +1.5 pp |
| 2020 | -53.5% | $-118.49 Million | $221.38 Million | $339.87 Million | ▼ -137.8 pp |
| 2019 | 84.3% | $120.68 Million | $143.12 Million | $22.44 Million | ▲ +4.1 pp |
| 2018 | 80.2% | $146.01 Million | $181.95 Million | $35.94 Million | ▼ -7.1 pp |
| 2017 | 87.4% | $218.84 Million | $250.44 Million | $31.60 Million | ▼ -5.0 pp |
| 2016 | 92.4% | $293.42 Million | $317.50 Million | $24.08 Million | ▼ -4.6 pp |
| 2015 | 97.0% | $356.00 Million | $366.85 Million | $10.85 Million | ▲ +1.0 pp |
| 2014 | 96.0% | $58.42 Million | $60.83 Million | $2.40 Million | ▲ +233.7 pp |
| 2013 | -137.7% | $-2.90 Million | $2.10 Million | $5.00 Million | — |